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Frequent reports on outbreaks of acute Chagas’ disease by ingestion of food contaminated with parasites from 
triatomine insects illustrate the importance of this mode of transmission. Studies on oral Trypanosoma cruzi infec-
tion in mice have indicated that metacyclic trypomastigotes invade the gastric mucosal epithelium. A key molecule 
in this process is gp82, a stage-specific surface glycoprotein that binds to both gastric mucin and to target epithelial 
cells. By triggering Ca2+ signalling, gp82 promotes parasite internalisation. Gp82 is relatively resistant to peptic 
digestion at acidic pH, thus preserving the properties critical for oral infection. The infection process is also influ-
enced by gp90, a metacyclic stage-specific molecule that negatively regulates the invasion process. T. cruzi strains 
expressing high gp90 levels invade cells poorly in vitro. However, their infectivity by oral route varies considerably 
due to varying susceptibilities of different gp90 isoforms to peptic digestion. Parasites expressing pepsin-susceptible 
gp90 become highly invasive against target cells upon contact with gastric juice. Such is the case of a T. cruzi isolate 
from an acute case of orally acquired Chagas’ disease; the gp90 from this strain is extensively degraded upon short 
period of parasite permanence in the gastric milieu. If such an exacerbation of infectivity occurs in humans, it may 
be responsible for the severity of Chagas’ disease reported in outbreaks of oral infection.
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In the past 20 years transmission of Trypanosoma 
cruzi, the causative agent of Chagas’ disease, has steep-
ly declined in Southern Cone primarily due to control 
measures directed at the elimination of the domiciliary 
vector, Triatoma infestans. Notwithstanding the success-
ful elimination of T. cruzi transmission by T. infestans 
in Brazil, Uruguay, Chile and substantial areas of Ar-
gentina, Bolivia and Paraguay (Schofield et al. 2006), 
many challenges remain. Increases in transmission have 
been reported in some areas of Argentina (Gürtler et al. 
2005), Venezuela (Feliciangeli et al. 2003) and in the 
Brazilian Amazon (Coura 2006). Several countries, in-
cluding Mexico, Peru, Colombia and Costa Rica, have 
not implemented a national programme for the control 
of T. cruzi transmission (Schofield et al. 2006). A matter 
of concern is also the report that wild populations of T. 
infestans are much more widespread throughout Bolivia 
than predicted, raising the possibility of a threat of re-
infestations of treated areas and the eventual spread to 
neighbouring regions (Noireau et al. 2005).
T. cruzi acquisition via the oral route has recently 
been the focus of attention. In Brazil, after the control of 
T. cruzi transmission through T. infestans and by blood 
transfusion, the most important and frequent mode of 
transmission is by the oral route (Coura 2006). Out-
breaks of acute Chagas’ disease through food contami-
nation have occurred in distinct regions of the country 
in the last four years. The occurrences have been more 
prevalent in the Amazon Region, where triatomines 
other than T. infestans predominate. According to Coura 
et al. (2002), more than 50% of acute cases of Chagas’ 
disease registered in the Brazilian Amazon between 
1968-2000 were attributable to microepidemics of orally 
transmitted infection.
Studies in mice have shown that insect-derived 
metacyclic trypomastigotes invade the gastric mucosal 
epithelium where the parasite replicates as amastigotes; 
no evidence of parasitic invasion anywhere within the 
oropharynx or oesophagus has been found (Hoft et al. 
1996). Metacyclic forms express mucin-like surface 
glycoproteins that are highly resistant to proteolytic deg-
radation (Mortara et al. 1992) and enable them to resist 
the harsh conditions in the stomach. This resistance to 
proteolysis of the mucins allows the metacyclic forms to 
proceed towards the target cells located in the gastric mu-
cosa (Yoshida 2006), which constitute the unique portal 
of entry to systemic infection (Hoft 1996). Contact with 
gastric juice does not diminish the parasite’s infectivity. 
In fact, some T. cruzi strains may become more invasive 
upon transient residence in the gastric milieu (Cortez et 
al. 2006b, Covarrubias et al. 2007). This report summa-
rises recent findings on the molecular mechanisms un-
derlying the process of gastric mucosal infection by me-
tacyclic trypomastigotes in a mouse model. Focused are 
also the questions of the modulation of T. cruzi infectivity 
by stomach components, which may either function as 
barriers to progression towards target cells or may act on 
parasites to render them more competent for invasion. 
This potential of stomach components to promote inva-
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sion may thus provide an explanation for the severity of 
Chagas’ disease in orally acquired infection.
Metacyclic stage-specific surface molecule gp82 
promotes T. cruzi infection by oral route
Experiments on oral infection in mice using metacy-
clic trypomastigotes generated in culture have indicated 
that the stage-specific surface glycoprotein gp82 plays a 
key role in the invasion of the gastric mucosal epithelium 
(Neira et al. 2003). Gp82 of different T. cruzi strains re-
sists degradation by pepsin at acidic pH, so that the para-
sites recovered from the stomach 1 h after oral inoculation 
into mice, preserve full infectivity (Cortez et al. 2006b). 
The process of gp82-dependent host cell invasion by me-
tacyclic forms has been partially elucidated by in vitro 
studies with human epithelial HeLa cells. Parasite-host 
cell interaction mediated by gp82 triggers in both cells 
signal transduction pathways that lead to intracellular 
Ca2+ mobilisation (Ruiz et al. 1998), an event essential for 
T. cruzi internalisation (Docampo & Moreno 1996, Bur-
leigh & Andrews 1998, Yoshida 2006). In the parasites, 
the Ca2+ response is induced upon recognition of gp82 by 
an as yet undefined host cell receptor expressed in mam-
malian cells that are susceptible to T. cruzi infection, 
such as HeLa and Vero cells, but not in T. cruzi-resistant 
cells such as the human leukaemia K562 cells (Yoshida 
et al. 2000). The events upstream of Ca2+ mobilization 
appear to involve the activation of the protein tyrosine 
kinase and phosphorylation of p175, a protein that is un-
detectable in noninfective epimastigotes (Favoreto et al. 
1998) and activation of phospholipase C. These pathways 
lead to the generation of inositol 1,4,5-triphosphate (IP3), 
which promotes Ca2+ release from IP3-sensitive stores 
(Yoshida et al. 2000).  In host cells, phosphoinositide-3 
kinase and protein kinase C appear to be part of the 
signalling cascades that culminate in Ca2+ mobilization 
from thapsigargin-susceptible compartments (Ferreira 
et al. 2006). Ca2+-dependent disorganization of the tar-
get cell actin cytoskeleton results from gp82-mediated 
parasite entry (Cortez et al. 2006a). This may contribute 
to efficient infection, provided that microfilament rear-
rangement facilitates T. cruzi internalisation (Rodriguez 
et al. 1995). Several pieces of evidence indicate that bi-
directional signalling triggered by gp82 ensures the most 
effective target cell invasion. Metacyclic forms of clone 
CL-14, for instance, which express gp82 at low levels 
but otherwise exhibit a surface profile indistinguishable 
from the highly invasive parental CL strain, invade cul-
tured HeLa cells poorly (Atayde et al. 2004).
Gp82 is encoded by a multigene family that is part of 
the trans-sialidase/gp85 superfamily, which is expressed 
at the infective trypomastigote stage (Araya et al. 1994). 
It is a glycoprotein that contains N-linked oligosaccha-
rides (Ramirez et al. 1993); however, the carbohydrate 
portion of the molecule is not involved in host cell bind-
ing. Therefore, the recombinant protein based on gp82 
generated in bacteria has the same cell binding capac-
ity as its endogenous counterpart (Ruiz et al. 1998). The 
gp82 molecule that has been identified by the monoclo-
nal antibody (MAb) 3F6, which inhibits infection in vi- 
tro and in vivo when parasites are orally administered, is 
highly conserved between genetically divergent T. cruzi 
strains. Analysis of the amino acid sequences of gp82, as 
deduced from cDNA clones of G and CL strain metacy-
clic forms, has revealed an overall identity of 97.9% and 
of 100% within the central domain containing the target 
cell binding site (Ruiz 1998). At the carboxy-terminal 
end of the central domain, the cell binding site for gp82 
is contiguous to, and partially overlapping, the epitope 
for MAb 3F6 (Manque et al. 2000). In addition to the cell 
invasion promoting activity, gp82 also has the ability to 
bind to gastric mucin.
Gastric epithelia are protected by an extracellular 
mucous layer whose major components are the high mo-
lecular mass mucins. During oral T. cruzi infection, the 
metacyclic trypomastigotes, upon reaching the stomach, 
bind to gastric mucin through gp82 as a first step to-
wards their destination, i.e., the mucosal epithelial cells. 
There have been reports that suggest that gp82 binds se-
lectively to gastric mucin and not, for instance, to mucin 
from submaxillary glands. This specificity may explain 
why, in orally inoculated mice, parasites are not found in 
the oropharynx or oesophagus (Hoft et al. 1996). Such 
selectivity may determine the stomach cells as the por-
tal of T. cruzi entry similar to the preferential adherence 
to colonic mucin of Shigella dysenteriae, whose patho-
genic potential is correlated with its ability to invade and 
multiply within the cells of colonic epithelium (Sudha et 
al. 2001). The importance of the gastric mucin-binding 
property of gp82 in the establishment of T. cruzi infec-
tion by the oral route has been confirmed by studies 
that have used parasite strains that were deficient in the 
expression of gp82. Metacyclic forms of gp82-deficient 
strains express the surface glycoprotein gp30 which in-
duces Ca2+ signalling in host cells and is also recognized 
by MAb 3F6 (Cortez et al. 2003). The lack of gp82 ex-
pression does not affect the parasite’s capacity to enter 
host cells in vitro, presumably because gp30 can fulfil 
the invasion-promoting function of gp82. Since the inva-
sion of the target cell by gp82-deficient parasites is in-
hibited to the same extent by either purified native gp30 
or by the recombinant gp82, it suggests that the same 
receptor may be recognizing these molecular species 
(Cortez et al. 2003).
While the in vitro infectivity of gp82-deficient T. 
cruzi strains is similar to that of the gp82-expressing 
CL strain, the course of infection upon oral administra-
tion in mice differs markedly. Gp82-deficient parasites 
produce very low parasitaemia levels, which may be at-
tributed to the poor affinity of gp30 for gastric mucin 
(Cortez et al. 2003). Studies that have used systems that 
mimic the in vivo conditions have demonstrated that 
poor adhesion to gastric mucin can interfere with para-
site entry into subjacent epithelial cells. In the presence 
of gastric mucin, penetration of gp82-deficient metacy-
clic trypomastigotes into HeLa cells was significantly 
reduced while the infectivity of gp82 expressing strains 
remained unaltered (Cortez et al. 2003). 
Based on the findings from experiments in mice and 
in cultured epithelial cells, using CL and gp82-deficient 
strains, the following picture is envisaged (Fig. 1). Upon 
oral inoculation, metacyclic forms reach the stomach lu-
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men, where the gp82-expressing parasites bind to gas-
tric mucin as an initial step for translocation towards 
the target epithelial cells; this process appears to require 
parasite energy. For metacyclic forms of gp82-deficient 
T. cruzi strains, which adhere, albeit poorly, to gastric 
mucin in gp30-mediated fashion, the mucus layer consti-
tutes a barrier that prevents most parasites from reaching 
the mucosal epithelium. Following the initial binding, 
the process of cell invasion is initiated (Fig. 2). Meta-
cyclic forms that express gp82 engage this molecule to 
accomplish the internalisation process by triggering 
the signalling cascades that lead to an increase in intra- 
cellular Ca2+ concentration. Gp82-deficient metacyclic 
forms that manage to traverse the mucus layer enter host 
cells in a gp30-mediated manner, thus inducing Ca2+ 
mobilization. After ~12 h post-invasion, most metacy-
clic forms have transformed into amastigotes, which go 
through replication cycles. By 96 h, nests of amastigotes 
are detectable at much higher numbers in the histologi-
cal preparations of the stomach of mice infected with 
gp82-expressing parasites than in sections from animals 
that were inoculated with gp82-deficient strains (Fig. 3). 
There is no difference between strains with regards to the 
rate of intracellular multiplication so that the release of 
trypomastigotes into the circulation should occur within 
a comparable time frame. However, reflecting the differ-
ence in the rate of invasion, parasitaemia levels in mice 
infected with gp82-deficient parasites are much lower 
than in mice inoculated with gp82-expressing parasites. 
It should be noted that the CL strain and the strains 
deficient in gp82 expression referred in this report ex-
press gp90 molecule at low levels (Cortez et al 2003). 
Therefore their infectivity is not influenced by this mol-
ecule. Gp90 is a metacyclic, stage-specific surface gly-
coprotein (Teixeira & Yoshida 1986) that is ubiquitously 
present in the T. cruzi population (Yoshida 2006). This 
surface molecule binds to mammalian cells in a receptor-
mediated manner without inducing Ca2+ response (Ruiz 
et al. 1998) and therefore acts as a negative regulator of 
target cell invasion (Málaga & Yoshida 2001).
Susceptibility of gp90 molecule to proteolysis influ-
ences T. cruzi infectivity by oral route
Expression of gp90, the metacyclic stage-specific 
surface glycoprotein that down modulates parasite in-
fectivity (Málaga & Yoshida 2001), varies in different 
T. cruzi strains and its expression in a strain is inversely 
correlated with the ability of that strain to invade cul-
Fig. 1: interaction of T. cruzi with gastric mucin in oral infection. 
Upon inoculation into mice (A), gp82-expressing and gp82-deficient 
metacyclic trypomastigotes reach the stomach lumen (B). Parasites 
expressing gp82 bind to gastric mucin in the mucous layer by 
engaging this surface molecule, as a first step towards underlying 
epithelial cells. By contrast, a few gp82-deficient parasites bind to 
gastric mucin, possibly using gp30.
Fig. 2: penetration of Trypanosoma cruzi into gastric epithelial cells 
in oral infection. Upon reaching the target cells, gp82-expressing 
metacyclic forms accomplish the invasion process by triggering the 
gp82-mediated signaling cascades that lead to an increase in intracel-
lular Ca2+ concentration. Metacyclic forms of gp82-deficient T. cruzi 
strains that managed to traverse the mucus layer enter host cells in 
gp30-mediated manner, inducing Ca2+ mobilization. The upper part 
of the figure is a composition of a histological section of mouse stom-
ach stained by hematoxylin-eosin and Giemsa-stained metacyclic try-
pomastigotes that are not in the same scale.
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tured mammalian cells (Ruiz et al. 1998, Yoshida 2006). 
Two variant forms of gp90 have been identified based 
on the reactivity with MAbs 1G7 and/or 5E7 (Teixeira 
& Yoshida 1986). The complete peptide sequence of ei-
ther of these gp90 molecules remains to be determined. 
Attempts to clone the gene encoding gp90 have, so far, 
been unsuccessful. What is known is that the sequence 
is present in multiple copies in the genome encodes 
a gp90 carboxy-terminal portion containing the epitope 
for MAb 5E7 (Franco et al. 1993), an antibody that 
reacts with metacyclic forms of all T. cruzi strains ex-
amined to date (Yoshida 2006). The recombinant protein 
corresponding to the carboxy-terminal domain of gp90 
binds to target cells in a receptor-mediated manner that 
is indistinguishable from that of native gp90 (Ruiz et al. 
1998). However, the receptors for the recombinant and 
the native molecules may be distinct. MAb 1G7, which 
does not react with the recombinant protein, binds to 
live metacyclic trypomastigotes and inhibits parasite-in-
duced intracellular Ca2+ mobilization (Ruiz et al. 1998). 
Thus, the gp90-reactive MAb 1G7 has an opposing ef-
fect to that of gp82-reactive MAb 3F6, which triggers 
an increase in cytosolic Ca2+ concentration upon bind-
ing to metacyclic forms (Ruiz et al. 1998). Of interest is 
that while MAb 3F6 induces the activation of the protein 
tyrosine kinase and phosphorylation of 175, (Favoreto et 
al. 1998), MAb 1G7 promotes p175 dephosphorylation 
(Manque et al. 2003). These findings are compatible 
with the idea that activation of protein tyrosine kinases 
and intracellular Ca2+ mobilization are associated events 
(Yoshida et al. 2000).
Metacyclic forms of T. cruzi strains expressing gp90 
at high levels invade cultured cells poorly. However, it is 
not possible to predict from this in vitro behaviour the 
course of infection after oral administration into mice. 
Recent studies have indicated that in vivo infectivity of 
these parasites is determined by gp90 susceptibility to 
peptic digestion. This notion is illustrated in the case 
of two T. cruzi strains that were derived from patients 
during the acute phase of the disease (Fig. 4). Metacy-
clic forms of these strains, which exhibited a similar 
surface profile (with high expression of gp82, gp30 and 
gp90), entered cultured epithelial cells at low numbers 
(Cortez et al. 2006b). This provides evidence that gp90-
mediated parasite-host cell interactions predominate 
over those interactions that are mediated by the gp82 
or gp30 molecules. When orally inoculated into mice, 
the two strains exhibited distinct infective properties. 
One of these strains entered gastric mucosal epithelial 
Fig. 4: increased infectivity of Trypanosoma cruzi strains express-
ing gp90 molecules susceptible to peptic digestion. Upon oral infec-
tion, metacyclic trypomastigotes of parasite strains bearing pepsin-
susceptible gp90* molecules express much less of these cell invasion 
down modulators, so that they can enter target cells more effectively. 
By contrast, parasites bearing pepsin-resistant gp90 molecules bind 
to target cells and relay inhibitory signal to both cells, thus hampering 
parasite entry.
Fig. 3: intracellular replication of Trypanosoma cruzi in gastric mu-
cosal epithelium. Following oral inoculation of metacyclic trypomas-
tigotes into mice, the parasites invade target cells in the stomach and 
replicate as amastigotes. Shown are the histological sections of the 
mouse stomach stained by hematoxylin-eosin four days post-infec-
tion. Nests of replicating amastigotes (white arrows) can be seen in 
higher numbers in mice infected with gp82-expressing parasites (A) 
than in animal inoculated with gp82-deficient strains (B).
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cells in high numbers and, as a consequence, resulted 
in a high number of replicating parasites in amastigote 
nests by day 4 as determined by haematoxylin-eosin 
stained histological sections of the stomach. At later 
times, the infected mice developed high parasitaemias 
and about 30% of them died within 30 days of infection. 
By analysing the parasites recovered from the mouse 
stomach 1 h after oral infection, the gp90 molecules was 
found to be  extensively degraded, in a manner similar 
to in vitro treatment of parasites with pepsin at acidic 
pH. Metacyclic forms with digested gp90, either upon 
transient residence in the gastric milieu or upon pepsin 
treatment in vitro, displayed an increased capacity to 
enter target cells (Cortez et al. 2006b). In contrast with 
these observations, mice inoculated with the second T. 
cruzi strain developed very low parasitaemias. Consis-
tent with this, at day 4 post-inoculation the number of 
amastigote nests found in the stomach was very low and 
mortality was null. Analysis of parasites recovered from 
the mouse stomach 1 h after oral infection showed that 
the gp90 molecule remained intact, thus explaining why 
metacyclic forms of this strain are as poorly infective 
in oral infection as they are towards cultured epithelial 
cells. It should be noted that, apart from the differen-
tial susceptibility of gp90 to peptic digestion, the two 
T. cruzi strains did not exhibit marked differences, with 
both strains preserving fully functional gp82 and gp30 
molecules after being recovered from the gastric milieu 
(Cortez et al. 2006b).
Overall, these findings suggest that the severity of 
acute Chagas’ disease that has been reported in patients 
infected by the oral route may be associated with up-
regulation of parasite infectivity, due to digestion of the 
cell invasion inhibitor, gp90. Support for this hypoth-
esis has been provided by the first study of a T. cruzi 
isolate derived from an acute case of Chagas’ disease 
acquired by oral route. This isolate, from an outbreak of 
oral T. cruzi infection that occurred in the southern state 
of Santa Catarina in 2005 and resulted in three deaths, 
was designated SC. Metacyclic trypomastigotes of SC, 
characterized by high levels of expression of gp82, gp30 
and gp90, entered host cells in culture at low rates (Co-
varrubias et al. 2007). When inoculated orally into mice, 
however, the parasites produced high parasitaemias and 
high mortality with more than 50% of infected animals 
being dead by day 20 post-inoculation. Analysis of SC 
parasites recovered from the mouse stomach 1 h after 
oral administration failed to detect the presence of gp90 
molecule, indicating that it was completely digested 
upon contact with the gastric juice. However, while the 
amino-terminal portion of gp82 was digested, the do-
main implicated in gastric mucin-binding and host cell 
invasion was fully preserved. With a fully functional 
gp82, in addition to a pepsin-resistant gp30, the inter-
nalisation of the parasite increased.
Do T. cruzi gp35/50 molecules play a role in oral 
infection?
T. cruzi strains referred to in preceding sections, 
derived mostly from chagasic patients, rely to a certain 
extent on gp82 or gp30 to establish infection in mice by 
oral route. For these strains, mucin-like surface glyco-
proteins primarily serve to protect the parasites against 
the action of gastric juice. However, gp35/50 mucins 
have an additional role in T. cruzi strains that prefer-
entially engage these molecules to invade target cells 
in vitro. Among T. cruzi strains examined to date, two 
groups have emerged based on the expression of mucin-
like gp35/50 glycoproteins: those reacting solely with 
MAb 2B10 and those reacting with both MAb 2B10 
and MAb 10D8. Strains from human origin that have 
been studied so far express gp35/50 molecules reactive 
with MAb 2B10 but not with MAb 10D8, whereas most 
strains derived from wild animals or wild triatomine in-
sects express MAb 10D8-reactive gp35/50 (Mortara et 
al. 1992). The gp35/50 mucins are encoded by a large 
multigene family (Di Noia et al. 1998) and are expressed 
in metacyclic forms as well as in epimastigotes (Yoshida 
et al. 1989). These mucins are GPI-anchored glycopro-
teins rich in threonine residues. In the protein core, gly-
cans are O-linked to the threonine residues through N-
acetylglucosamine rather than N-acetylgalactosamines 
as usually found in vertebrate mucins. (Schenkman et al. 
1993). Depending on the T. cruzi strain, they may contain 
galactofuranose residues in addition to galactopyranose 
(Previato et al. 1994, Acosta-Serrano et al. 1995, Salto et 
al. 2000). MAb 10D8 reacts with gp35/50 epitopes con-
taining galactofuranose, whereas MAb 2B10 appears to 
recognize galactopyranose-containing epitopes present 
in all strains. Several lines of evidence have indicated 
that MAb 10D8-reactive gp35/50 is implicated in host cell 
invasion as both the antibody and the purified mucin are 
capable of inhibiting parasite internalisation (Yoshida et 
al. 1989, Ruiz et al. 1993). Gp35/50 glycoprotein binds to 
target cells in a receptor-mediated manner and induces 
a bidirectional Ca2+ response, but to a lesser degree than 
gp82 (Ruiz et al. 1998). It is possible that most parasite 
strains that rely preferentially on gp35/50 to enter host 
cells are poorly invasive because of the relatively weak 
signalling activity of these molecules. However, the low 
invasive capacity may also be due to the expression of 
gp90, which in general is present at high levels in meta-
cyclic forms of T. cruzi strains that are recognized by 
MAb 10D8 (Yoshida 2006). As these strains also exhibit 
high expression of gp82, the results support the hypoth-
esis that the gp90-mediated interaction with the host 
cell is dominant acting. Gp35/50 mucins contain sialic 
acid but sialyl residues are not required for invasion and, 
depending on the parasite strain, they may even impair 
recognition by target cells (Yoshida et al. 1997). For in-
stance, treatment of metacyclic forms of G strain with 
bacterial neuraminidase removes gp35/50 sialic acid and 
increases the parasite infectivity (Yoshida et al. 1997). 
This can be reverted by resialylation of gp35/50 upon 
incubating the parasites with T. cruzi trans-sialidase and 
sialyl lactose, which results in parasite internalisation to 
similar levels as that seen before desialylation. Consis-
tent with this result, the ability of desialylated gp35/50 
to bind to target cells and to trigger Ca2+ response was 
found to be higher than that of its sialylated counterpart 
(Yoshida et al. 1997).
G strain metacyclic forms that engage MAb 10D8-
reactive gp35/550 mucins to enter host cells in vitro are 
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poorly infective when given orally into mice and fail to 
produce detectable parasitaemia upon microscopic ex-
amination of blood samples (Yoshida 2006). Analysis of 
histological preparations of stomach from mice infected 
with G strain has revealed very scarce parasites. These 
observations are consistent with the fact that this strain 
expresses high levels of a gp90 isoform resistant to peptic 
digestion (Covarrubias et al. 2007). If metacyclic forms 
expressing 10D8-reactive gp35/50, but not gp90, could 
be generated, the role of T. cruzi mucins in infection in 
vivo may be clarified. Finding proteases and/or condi-
tions that preserve the gp35/50 molecules and degrade 
gp90 would facilitate researchers to gain insight into the 
role that mucins play in infection.
Studies on experimental oral infection by T. cruzi 
metacyclic trypomastigotes, in parallel with in vitro ep-
ithelial cell invasion assays, have revealed several fea-
tures of parasite-host interactions, which would not have 
been predicted soley based on in vitro experiments. The 
gastric mucosal epithelium as the preferential portal of 
entry for metacyclic forms inoculated in mice by the 
oral route may be due to the selective binding of para-
sites to the gastric mucin. In the gastric milieu, metacy-
clic forms resist digestion due to the presence of surface 
mucin-like gp35/50 glycoproteins. Metacyclic stage-
specific surface molecule gp82, implicated in gastric 
mucin-binding and in promoting host cell invasion, is 
relatively resistant to peptic digestion and remains fully 
functional upon transient contact with gastric juice. 
Gp90, a metacyclic stage-specific surface molecule 
that functions as a negative regulator of target cell en-
try and is the main determinant of parasite infectivity, 
has strain-dependent susceptibility to proteolysis. Me-
tacyclic forms expressing gp82 and gp90 at low levels 
traverse the mucous layer protecting the gastric mucosa 
through gp82-mediated binding to its major compo-
nents, the mucin molecules, and efficiently invade the 
target epithelial cells engaging gp82. For metacyclic 
forms deficient in gp82, the mucous layer represents a 
barrier that hampers the journey towards host cells. For 
T. cruzi strains that express the cell invasion-promoting 
molecules gp82 and gp30, in addition to gp90 at high 
levels, their infectivity will be determined by the sus-
ceptibility of gp90 isoform to peptic digestion. If they 
express pepsin-resistant gp90, they will be poorly infec-
tive. However, if they express pepsin-susceptible gp90 
molecules, they can become highly infective upon ex-
posure to gastric juice. The latter situation appears to 
be the case in a T. cruzi isolate from an acute case of 
Chagas’ disease acquired by oral infection, which had 
its infectivity enhanced in the mouse gastric milieu.
ACKNOWLEDGEMENTS
To Dr. Clara Lucia Barbieri and Dr. Rafael Miyazawa 
Martins, for reading the manuscript.
REFERENCES
Acosta AS, Schenkman S, Yoshida N, Mehler A, Richardson JM, Fer-
guson MAJ 1995. The lipid structure of the GPI-anchored mucin-
like sialic acid acceptors of Trypanosoma cruzi changes during 
parasite differentiation from epimastigotes to infective metacy-
clic trypomastigote forms. J Biol Chem 270: 27244-27253.
Araya JE, Cano MI, Yoshida N, Franco da Silveira J 1994. Clon-
ing and characterization of a gene for the stage-specific 82-kDa 
surface antigen of metacyclic trypomastigotes of Trypanosoma 
cruzi. Mol Biochem Parasitol 65: 161-169.
Atayde VD, Neira I, Cortez M, Ferreira D, Freymuller E, Yoshida 
N 2004. Molecular basis of non virulence of Trypanosoma cruzi 
clone CL-14. Int J Parasitol 34: 851-860.
Burleigh BA, Andrews NW 1998. Signaling and host cell invasion by 
Trypanosoma cruzi. Curr Opinion Microbiol 1: 451-465.
Cortez M, Atayde V, Yoshida N 2006a. Host cell invasion mediated 
by Trypanosoma cruzi surface molecule gp82 is associated with 
F-actin disassembly and is inhibited by enteroinvasive Escheri-
chia coli. Microbes Infect 8: 1502-1512.
Cortez M, Neira I, Ferreira D, Luquetti AO, Rassi A, Atayde VD, 
Yoshida N 2003. Infection by Trypanosoma cruzi metacyclic 
forms deficient in gp82 but expressing a related surface molecule 
gp30. Infect Immun 71: 6184-6191.
Cortez M, Silva MR, Neira I, Ferreira D, Sasso GRS, Luquetti AO, 
Rassi A, Yoshida N 2006b. Trypanosoma cruzi surface molecule 
gp90 downregulates invasion of gastric mucosal epithelium in 
orally infected mice. Microbes Infect 8: 36-44.
Coura JR 2006. Transmission of chagasic infection by oral route in 
the natural history of Chagas’ disease. Rev Soc Bras Med Trop 
39 (Suppl. 3): 113-117.
Coura JR, Junqueira ACV, Fernandes O, Valente SAS, Miles MA 
2002. Emerging Chagas’ disease in Amazonian Brazil. Trends 
Parasitol 18: 171-176.
Covarrubias C, Cortez M, Ferreira D, Yoshida N 2007. Interaction 
with host factors exacerbate Trypanosoma cruzi cell invasion ca-
pacity upon oral infection. Int J Parasitol 37: 1609-1616.
Di Noia JM, D’Orso I, Aslund I, Sanchez DO, Frasch AC 1998. The 
Trypanosoma cruzi mucin family is transcribed from hundreds 
of genes having hypervariable regions. J Biol Chem 273: 10843-
10850.
Docampo R, Moreno SJ 1996. The role of Ca2+ in the process of cell 
invasion by intracellular parasites. Parasitol Today 12: 61-65.
Favoreto Jr S, Dorta ML, Yoshida N 1998. Trypanosoma cruzi 175 
kDa protein tyrosine phosphorylation is associated with host cell 
invasion. Exp Parasitol 89: 188-194.
Feliciangeli MD, Campbell-Lendrum D, Martinez C, Gonzalez D, 
Coleman P, Davies C 2003. Chagas’ disease control in Venezu-
ela: lessons for the Andean Region and beyond. Trends Parasitol 
19: 44-49.
Ferreira D, Cortez M, Atayde VD, Yoshida N 2006. Actin cytoskel-
eton-dependent and independent host cell invasion by Trypano-
soma cruzi is mediated by sdistinct parasite surface molecules. 
Infect Immun 74: 5522-5528.
Franco FRS, Paranhos-Bacalla GS, Yamauchi LM, Yoshida N, Franco 
da Silveira J 1993. Characterization of a cDNA clone encoding 
the carboxy-terminal domain of a 90-kilodalton surface antigen 
of Trypanosoma cruzi metacyclic trypomastigotes. Infect Immun 
61: 4196-4201.
Gürtler RE, Cecere MC, Lauricella MA, Petersen RM, Chuit R, Se-
gura EL, Cohen JE 2005. Incidence of Trypanosoma cruzi infec-
tion among children following domestic infestation after insecti-
cide spraying in rural Northwestern Argentina. Am J Trop Med 
Hyg 73: 95-103.
107Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 104(Suppl. I), 2009
Hoft DF 1996. Differential mucosal infectivity of different life stages 
of Trypanosoma cruzi. Am J Trop Med Hyg 55: 360-364.
Hoft DF, Farrar PL, Kratz-Owens K, Shaffer D 1996. Gastric inva-
sion by Trypanosoma cruzi and induction of protective mucosal 
immune responses. Infect Immun 64: 3800-3810.
Málaga S, Yoshida N 2001. Targeted reduction in expression of Try-
panosoma cruzi surface glycoprotein gp90 increases parasite in-
fectivity. Infect Immun 69: 353-359.
Manque PM, Eichinger D,  Juliano MA, Juliano L, Araya J, Yoshida N 
2000. Characterization of the cell adhesion site of Trypanosoma 
cruzi metacyclic stage surface glycoprotein gp82. Infect Immun 
68: 478-484.
Manque PM, Neira I, Atayde VD, Cordero E, Ferreira AT, Franco 
da Silveira J, Ramirez M, Yoshida N 2003. Cell adhesion and 
Ca2+ signaling activity in stably transfected Trypanosoma cruzi 
epimastigotes expressing the metacyclic stage-specific surface 
molecule gp82. Infect Immun 71: 1561-1565.
Mortara RA, Silva S, Araguth MF, Blanco SA, Yoshida N 1992. Poly-
morphism of the 35- and 50-kilodalton surface glycoconjugates 
of Trypanosoma cruzi metacyclic trypomastigotes. Infect Immun 
60: 4673-4678.
Neira I, Silva FA, Cortez M, Yoshida N 2003. Involvement of Try-
panosoma cruzi metacyclic trypomastigote surface molecule 
gp82 in adhesion to gastric mucin and invasion of epithelial cells. 
Infect Immun 71: 557-561.
Noireau F, Cortez MGR, Monteiro FA, Jansen AM, Torrico F 2005. 
Can wild Triatoma infestans foci in Bolívia jeopardize Chagas’ 
disease control efforts? Trends Parasitol 21: 7-10.
Previato JO, Jones C, Gonçalves LP, Wait R, Travassos LR, Mendon-
ça-Previato L 1994. O-glycosidically linke N-acetylglucosamine-
bound oligosaccharides from glycoproteins of Trypanosoma cru-
zi. Biochem J 301: 151-159.
Ramirez MI, Ruiz RC, Araya JE, Franco da Silveira J, Yoshida N 
1993. Involvement of the stage-specific 82-kilodalton adhesion 
molecule of Trypanosoma cruzi metacyclic trypomastigotes in 
host cell invasion. Infect Immun 61: 3636-3641.
Rodriguez A, Rioult MG, Ora A, Andrews NW 1995. A trypanosome-
soluble factor induces IP3 formation, intracellular Ca
2+ mobiliza-
tion and microfilament rearrangement in host cells. J Cell Biol 
129: 1263-1273.
Ruiz RC 1998. Trypanosoma cruzi: associação entre infectividade 
e expressão de glicoproteínas com atividade sinalizadora de 
cálcio, PhD Thesis, Universidade Federal de São Paulo, São 
Paulo, 107p.
 Ruiz RC, Favoreto S, Dorta ML, Oshiro MEM, Ferreira AT, Manque 
PM, Yoshida N 1998. Infectivity of Trypanosoma cruzi strains is 
associated with differential expression of surface glycoproteins 
with differential Ca2+ signaling activity. Biochem J 330: 505-511.
Ruiz RC, Rigoni VLl, Gonzalez J, Yoshida N 1993. The 35/50 kDa 
surface antigen of Trypanosoma cruzi metacyclic trypomasti- 
gotes, an adhesion molecule involved in host cell invasion. Para-
site Immunol 15: 121-123.
Salto ML, Gallo-Rodriguez C, Lima C, Lederkremer RM 2000. Sepa-
ration of galfbeta1→ XGlcNAc and galpbeta1→ XGlcNAc (X = 
3, 4 and 6) as the  alditols by high-pH aninon-exchange chro-
matography and thin-layer chromatography: characterization of 
mucins from Trypanosoma cruzi. Anal Biochem 279: 79-84.
Schenkman S, Ferguson MAJ, Heise N, Cardoso de Almeida ML, 
Mortara RA, Yoshida N 1993. Mucin-like glycoproteins linked 
to the membrane by glycosylphosphatidylinositol anchor are the 
major acceptors of sialic acid in a reaction catalysed by trans-sial-
idase in metacyclic forms of Trypanosoma cruzi. Mol Biochem 
Parasitol 59: 293-304.
Schofield CJ, Jannin J, Salvatella R 2006. The future of Chagas’ dis-
ease control. Trends Parasitol 22: 583-588.
Sudha PS, Devaraj H, Devaraj N 2001. Adherence of Shigella dysen-
teriae to human colonic mucin. Curr Microbiol 42: 381-387.  
Teixeira MMG, Yoshida N 1986. Stage-specific surface antigens 
identified by monoclonal antibodies. Mol Biochem Parasitol 18: 
271-282. 
Yoshida N 2006. Molecular basis of mammalian cell invasion of Try-
panosoma cruzi. An Acad Bras Cienc 78: 87-111. 
Yoshida N, Dorta ML, Ferreira AT, Oshiro MEM, Mortara RA, Acos-
ta-Serrano A, Favoreto Jr S 1997. Removal of sialic acid from 
mucin-like surface molecules of Trypanosoma cruzi  metacyclic 
trypomastigotes enhances parasite-host cell interaction. Mol Bio-
chem Parasitol 84: 57-67.
Yoshida N, Favoreto Jr S, Ferreira AT, Manque PM 2000. Signal 
transduction induced in Trypanosoma cruzi metacyclic trypo-
mastigotes during the invasion of mammalian cells. Braz J Med 
Biol Res 33: 269-278.
Yoshida N, Mortara RA, Araguth MF, Gonzalez JC, Russo M 1989. 
Metacyclic neutralizing effect of monoclonal antibody 10D8 
directed to the 35 and 50-kilodalton surface glycoconjugates of 
Trypanosoma cruzi.  Infect Immun 57: 1663-1667.
